Matches in SemOpenAlex for { <https://semopenalex.org/work/W1514713080> ?p ?o ?g. }
- W1514713080 abstract "Background Borderline Personality Disorder (BPD) is prevalent (2% in the general population, 20% among psychiatry in‐patients) and has a major impact on health facilities as those affected often present in crisis but then make poor use of further attempts to help them. Objectives To evaluate the effects of pharmacological interventions for people with borderline personality disorder. Search methods We conducted a systematic search of 26 specialist and general bibliographic databases (October 2002) and searched relevant reference lists for further trials. Selection criteria We included all randomised clinical trials comparing any psychoactive drugs with any other treatment for people with borderline personality disorder. Data collection and analysis We independently selected, quality assessed and data extracted studies. For binary outcomes we calculated a standard estimation of the risk ratio (RR), its 95% confidence interval (CI), and where possible the number need to help/harm (NNT/H). For continuous outcomes, endpoint data were preferred to change data. Non‐skewed data from valid scales were synthesised using a weighted mean difference (WMD). Main results We found ten small (total n=554), short, randomised studies involving eight comparisons from which we could extract usable data. Studies comparing antidepressants with placebo were small (total n=79, 2 RCTs) but for ratings of anger fluoxetine may offer some improvement for those on antidepressant therapy over placebo (n=22, 1 RCT, RR anger not improved 0.30 CI 0.10 to 0.85, NNT 2 CI 2 to 9). The one small study investigating the important outcome of attempted suicide found no difference between mianserin and placebo (n=38, 1 RCT, RR 0.82 CI 0.44 to 1.54). Haloperidol may be better than antidepressants for symptoms of hostility and psychotism. There were few differences between MAOIs and placebo except that people given MAOIs were less hostile (n=62, 1 RCT, MD ‐9.19 CI ‐16.12 to ‐2.26). Although some ratings were statistically significant the comparison of MAOIs with antipsychotics did not show convincing differences. Antipsychotics may effect some mental state symptoms more effectively than placebo but results are difficult to interpret clinically and there is little evidence of advantage of one antipsychotic over another. Finally mood stabilisers such as divalporex may help mental state (n=16, 1 RCT, RR no improvement in mental state 0.58 CI 0.36 to 0.94, NNT 3 CI 2 to 17) but data are far from conclusive. Authors' conclusions Pharmacological treatment of people with BPD is not based on good evidence from trials and it is arguable that future use of medication should be from within randomised trials. Current trials suggest that the positive effect of antidepressants, in particular, could be considerable. Well designed, conducted and reported clinically meaningful trials are possible and needed with, perhaps, the question of antidepressant versus placebo being addressed first." @default.
- W1514713080 created "2016-06-24" @default.
- W1514713080 creator A5028903775 @default.
- W1514713080 creator A5049523292 @default.
- W1514713080 creator A5075924030 @default.
- W1514713080 creator A5081088301 @default.
- W1514713080 creator A5084177550 @default.
- W1514713080 creator A5085074957 @default.
- W1514713080 date "2006-01-25" @default.
- W1514713080 modified "2023-10-18" @default.
- W1514713080 title "Pharmacological interventions for people with borderline personality disorder" @default.
- W1514713080 cites W1591259115 @default.
- W1514713080 cites W172978298 @default.
- W1514713080 cites W1745517822 @default.
- W1514713080 cites W182725121 @default.
- W1514713080 cites W1963909717 @default.
- W1514713080 cites W1968607731 @default.
- W1514713080 cites W1974384388 @default.
- W1514713080 cites W1977185679 @default.
- W1514713080 cites W1978040764 @default.
- W1514713080 cites W1984937481 @default.
- W1514713080 cites W1990256375 @default.
- W1514713080 cites W1994510815 @default.
- W1514713080 cites W1994550894 @default.
- W1514713080 cites W2000324661 @default.
- W1514713080 cites W2002046627 @default.
- W1514713080 cites W2017306771 @default.
- W1514713080 cites W2022864353 @default.
- W1514713080 cites W2023839473 @default.
- W1514713080 cites W2042241860 @default.
- W1514713080 cites W2043666690 @default.
- W1514713080 cites W2045857358 @default.
- W1514713080 cites W2045886379 @default.
- W1514713080 cites W2046612400 @default.
- W1514713080 cites W2052002050 @default.
- W1514713080 cites W2058874144 @default.
- W1514713080 cites W2061838800 @default.
- W1514713080 cites W2067495470 @default.
- W1514713080 cites W2067791685 @default.
- W1514713080 cites W2074190077 @default.
- W1514713080 cites W2074930596 @default.
- W1514713080 cites W2076611498 @default.
- W1514713080 cites W2090513691 @default.
- W1514713080 cites W2107499882 @default.
- W1514713080 cites W2114613490 @default.
- W1514713080 cites W2119226169 @default.
- W1514713080 cites W2125435699 @default.
- W1514713080 cites W2129622235 @default.
- W1514713080 cites W2135029321 @default.
- W1514713080 cites W2140608240 @default.
- W1514713080 cites W2152240392 @default.
- W1514713080 cites W2153766828 @default.
- W1514713080 cites W2157823046 @default.
- W1514713080 cites W2157877920 @default.
- W1514713080 cites W2315234212 @default.
- W1514713080 cites W2413835632 @default.
- W1514713080 cites W4320288061 @default.
- W1514713080 cites W62717218 @default.
- W1514713080 doi "https://doi.org/10.1002/14651858.cd005653" @default.
- W1514713080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16437535" @default.
- W1514713080 hasPublicationYear "2006" @default.
- W1514713080 type Work @default.
- W1514713080 sameAs 1514713080 @default.
- W1514713080 citedByCount "64" @default.
- W1514713080 countsByYear W15147130802012 @default.
- W1514713080 countsByYear W15147130802013 @default.
- W1514713080 countsByYear W15147130802014 @default.
- W1514713080 countsByYear W15147130802016 @default.
- W1514713080 countsByYear W15147130802017 @default.
- W1514713080 countsByYear W15147130802018 @default.
- W1514713080 countsByYear W15147130802019 @default.
- W1514713080 countsByYear W15147130802022 @default.
- W1514713080 countsByYear W15147130802023 @default.
- W1514713080 crossrefType "reference-entry" @default.
- W1514713080 hasAuthorship W1514713080A5028903775 @default.
- W1514713080 hasAuthorship W1514713080A5049523292 @default.
- W1514713080 hasAuthorship W1514713080A5075924030 @default.
- W1514713080 hasAuthorship W1514713080A5081088301 @default.
- W1514713080 hasAuthorship W1514713080A5084177550 @default.
- W1514713080 hasAuthorship W1514713080A5085074957 @default.
- W1514713080 hasBestOaLocation W15147130802 @default.
- W1514713080 hasConcept C118552586 @default.
- W1514713080 hasConcept C126322002 @default.
- W1514713080 hasConcept C142724271 @default.
- W1514713080 hasConcept C168563851 @default.
- W1514713080 hasConcept C170493617 @default.
- W1514713080 hasConcept C204787440 @default.
- W1514713080 hasConcept C27081682 @default.
- W1514713080 hasConcept C27415008 @default.
- W1514713080 hasConcept C2775864247 @default.
- W1514713080 hasConcept C2776134451 @default.
- W1514713080 hasConcept C2779302386 @default.
- W1514713080 hasConcept C2780600973 @default.
- W1514713080 hasConcept C2908647359 @default.
- W1514713080 hasConcept C44249647 @default.
- W1514713080 hasConcept C67774102 @default.
- W1514713080 hasConcept C70410870 @default.
- W1514713080 hasConcept C71924100 @default.
- W1514713080 hasConcept C82789193 @default.
- W1514713080 hasConcept C99454951 @default.